The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children

Last updated: July 14, 2020
Sponsor: Dalia Mahran
Overall Status: Active - Recruiting

Phase

N/A

Condition

Molluscum Contagiosum

Sexually Transmitted Diseases (Stds)

Treatment

N/A

Clinical Study ID

NCT04476186
site of study assiut U H
  • Ages 2-16
  • All Genders

Study Summary

The investigators will study the effectiveness of acyclovir in the treatment of molluscum contagiosum in assiut university hospital - dermatological out patient clinic the treatment group will receive acyclovir 200 mg 5 times per day the controlled group will receive local KOH solution

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Children (2 -16) years old with Molluscum contagiosum.

Exclusion

Exclusion Criteria:

  • Molluscum contagiosum with Inflamed spot Known immune compromised children Molluscumlesion in the eye lid. Children with renal impairment.

Study Design

Total Participants: 35
Study Start date:
June 15, 2020
Estimated Completion Date:
December 30, 2021

Study Description

Study population:

Site of the study: The outpatient dermatological clinic in Assiut university hospital.

Participants: children (2 -16) years' old attending dermatological clinic in Assiut university hospital and their parents.

Methodology in details:

  1. We will use the social media as " Facebook" to invite patient to visit the clinic and follow up them due to the protective measures of covid 19.

  2. Diagnosis of the patient with molluscum contagiosum according to the clinical picture

  3. Collecting data including personal and clinical data through interviewing the patient and his or her parents

  4. Pictures of the lesions will be taken before and after treatment after patient consent.

  5. We will Randomly assigning the patient to either treatment group or controlled group according to simple random table

  6. Prescribing the treatment according to the patient group

  7. Follow up of the patient after 1 weak and each week according to the response to treatment or presence of complication

Inclusion criteria:

Children (5 -15) years old with Molluscum contagiosum.

Exclusion criteria:

  1. Molluscum contagiosum with Inflamed spot

  2. Known immune compromised children

  3. Molluscum lesion in the eye lid.

  4. Children with renal impairment.

Connect with a study center

  • Hamdy Gomaa

    Assiut, New Assiut City 71684
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.